*Stakeholders in Pharmaceutical Policy Development DOI: http://dx.doi.org/10.5772/intechopen.105606*

health, including poverty, and the social determinants of equity, including racism, if they seek to improve health outcomes and eliminate health disparities through their policies. Achieving health equity requires valuing everyone equally with focused and ongoing societal efforts to address avoidable inequalities, historical and contemporary injustices, and the elimination of health and health care disparities [29]. Without the due recognition of these rights of patients any policy development process will be incomplete and inadequate and will not be result-oriented so far as patient satisfaction and well-being is concerned. In fact all drug policy provisions must have the patient as their main focus of attention while being drafted and finalized and the policy planning must be directed at giving maximum relief and benefit to the patients rather than the pharmaceutical industry or the traders.
